Skip Nav Destination
Issues
November 2018
ISSN 2296-5270
EISSN 2296-5262
In this Issue
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2018, Vol. 41, No. 11
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 669–673.
https://doi.org/10.1159/000494599
Editorial
Uterine Sarcoma - Difficult to Diagnose, Hard to Treat
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 674.
https://doi.org/10.1159/000494393
Review Article
Uterine Carcinosarcomas - Diagnosis and Management
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 675–679.
https://doi.org/10.1159/000494335
Uterine Leiomyosarcoma
Special Collection:
Focus Article
Subject Area:
Oncology
Ingolf Juhasz-Böss; Lena Gabriel; Rainer M. Bohle; Lars C. Horn; Erich-Franz Solomayer; Georg-Peter Breitbach
Oncol Res Treat (2018) 41 (11): 680–686.
https://doi.org/10.1159/000494299
Low-Grade Endometrial Stromal Sarcoma - a Review
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 687–692.
https://doi.org/10.1159/000494225
Uterine Adenosarcoma
Special Collection:
Focus Article
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 693–696.
https://doi.org/10.1159/000494067
Research Article
Return to Work in Patients with Hematological Cancers 1 Year after Treatment: A Prospective Longitudinal Study
Subject Area:
Oncology
Tim J. Hartung; Leon P. Sautier; Angela Scherwath; Kirsten Sturm; Nicolaus Kröger; Uwe Koch; Anja Mehnert
Oncol Res Treat (2018) 41 (11): 697–701.
https://doi.org/10.1159/000491589
Single-Fraction Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Relapse in Prostate Cancer
Subject Area:
Oncology
Mauro Loi; Vanessa Di Cataldo; Giulio Francolini; Pierluigi Bonomo; Laura Masi; Gabriele Simontacchi; Beatrice Detti; Daniela Greto; Isacco Desideri; Lorenzo Livi
Oncol Res Treat (2018) 41 (11): 703–705.
https://doi.org/10.1159/000491605
Association between MRI Features and Standardized Uptake Value of 18F-FDG PET/CT in Triple-Negative Breast Cancer
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 706–711.
https://doi.org/10.1159/000492341
Review Article
Hematological Toxicity of Hypofractionated Radiotherapy: A Review of the Available Evidence
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 713–718.
https://doi.org/10.1159/000492342
PharmaForum
Afatinib in der Erstlinie beim EGFR-mutierten NSCLC. Patientenindividuelle Sequenzplanung mit Tyrosinkinaseinhibitoren (TKI)
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 719.
https://doi.org/10.1159/000494600
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 720.
https://doi.org/10.1159/000494601
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 721–723.
https://doi.org/10.1159/000494420
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2018) 41 (11): 725–728.
https://doi.org/10.1159/000494418
